Giuseppe Tonini

34.5k total citations · 4 hit papers
530 papers, 17.6k citations indexed

About

Giuseppe Tonini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Giuseppe Tonini has authored 530 papers receiving a total of 17.6k indexed citations (citations by other indexed papers that have themselves been cited), including 314 papers in Oncology, 207 papers in Pulmonary and Respiratory Medicine and 107 papers in Molecular Biology. Recurrent topics in Giuseppe Tonini's work include Colorectal Cancer Treatments and Studies (109 papers), Bone health and treatments (63 papers) and Cancer Treatment and Pharmacology (56 papers). Giuseppe Tonini is often cited by papers focused on Colorectal Cancer Treatments and Studies (109 papers), Bone health and treatments (63 papers) and Cancer Treatment and Pharmacology (56 papers). Giuseppe Tonini collaborates with scholars based in Italy, United States and United Kingdom. Giuseppe Tonini's co-authors include Daniele Santini, Bruno Vincenzi, Alfredo Falcone, Fotios Loupakis, Francesco Graziano, Chiara Cremolini, Gaia Schiavon, Francesco Pantano, Gianluca Masi and Annamaria Ruzzo and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Giuseppe Tonini

503 papers receiving 17.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

2015 733 citations Alberto Zaniboni, Giuseppe Tonini et al. profile →
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

2014 720 citations Alberto Zaniboni, Giuseppe Tonini et al. profile →
Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)

2006 694 citations Giuseppe Tonini et al. profile →
Gut Microbiota and Cancer: From Pathogenesis to Therapy

2019 408 citations Giuseppe Tonini et al. Cancers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giuseppe Tonini Italy	62	8.8k	4.8k	4.1k	2.9k	2.3k	530	17.6k
Keitaro Matsuo Japan	71	6.4k 0.7×	5.5k 1.2×	4.3k 1.1×	4.0k 1.4×	2.5k 1.1×	736	21.4k
Thomas S. Murray United States	11	6.9k 0.8×	5.8k 1.2×	5.2k 1.3×	3.0k 1.0×	2.8k 1.2×	14	17.6k
Dino Amadori Italy	60	6.7k 0.8×	4.5k 0.9×	3.1k 0.8×	1.6k 0.6×	4.3k 1.9×	351	14.2k
Emile E. Voest Netherlands	70	8.5k 1.0×	7.3k 1.5×	3.1k 0.8×	1.4k 0.5×	4.9k 2.1×	370	18.8k
Daniele Santini Italy	63	8.8k 1.0×	4.0k 0.8×	4.1k 1.0×	2.5k 0.9×	2.6k 1.1×	618	15.1k
Donna Niedzwiecki United States	71	11.4k 1.3×	3.7k 0.8×	4.7k 1.2×	4.2k 1.5×	2.1k 0.9×	390	19.0k
Hys Ngan Hong Kong	68	4.1k 0.5×	6.9k 1.4×	2.1k 0.5×	3.8k 1.3×	3.4k 1.5×	521	21.5k
Christoph Röcken Germany	71	5.3k 0.6×	8.2k 1.7×	2.2k 0.5×	2.6k 0.9×	2.3k 1.0×	474	17.2k
Helmut Friess Germany	81	12.3k 1.4×	7.6k 1.6×	3.8k 0.9×	6.9k 2.4×	3.2k 1.4×	355	21.8k
Valter Torri Italy	66	8.8k 1.0×	2.6k 0.5×	7.2k 1.8×	3.8k 1.3×	2.5k 1.1×	305	21.2k

Countries citing papers authored by Giuseppe Tonini

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Tonini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Tonini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Tonini more than expected).

Fields of papers citing papers by Giuseppe Tonini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Tonini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Tonini. The network helps show where Giuseppe Tonini may publish in the future.

Co-authorship network of co-authors of Giuseppe Tonini

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Tonini. A scholar is included among the top collaborators of Giuseppe Tonini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Tonini. Giuseppe Tonini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garofalo, Stefano, et al.. (2025). Patient-Reported Outcome Measurement and Reporting for Patients with Soft Tissue Tumors: A Scoping Literature Review. Cancers. 17(14). 2280–2280.

Fassan, Matteo, Valentina Angerilli, Nicola Normanno, et al.. (2024). Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper. Critical Reviews in Oncology/Hematology. 194. 104224–104224. 8 indexed citations

Nenna, Antonio, Francesco Nappi, Camilla Chello, et al.. (2024). miRNAs in the diagnosis and therapy of cardiac and mediastinal tumors: a new dawn for cardio-oncology?. Future Cardiology. 20(14). 795–806. 1 indexed citations

Papalia, Giuseppe Francesco, Eliodoro Faiella, Domiziana Santucci, et al.. (2024). Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review. Cancers. 16(15). 2700–2700. 13 indexed citations

Ribolsi, Michele, et al.. (2023). Defense style and psychopathology in oncological patients: a preliminary report. Recenti Progressi in Medicina. 114(11). 665–668.

Muscaritoli, Maurizio, Alessandra Modena, Paolo Marchetti, et al.. (2023). The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study. Cancers. 15(12). 3206–3206. 9 indexed citations

Pezzuto, Aldo, Giuseppe Tonini, Massimo Ciccozzi, et al.. (2022). Functional Benefit of Smoking Cessation and Triple Inhaler in Combustible Cigarette Smokers with Severe COPD: A Retrospective Study. Journal of Clinical Medicine. 12(1). 234–234. 15 indexed citations

Garbarino, Giovanni Maria, Giovanni Guglielmo Laracca, Alessio Lucarini, et al.. (2022). Laparoscopic versus Open Surgery for Gastric Cancer in Western Countries: A Systematic Review and Meta-Analysis of Short- and Long-Term Outcomes. Journal of Clinical Medicine. 11(13). 3590–3590. 18 indexed citations

Aglietta, Massimo, Vanna Chiarion‐Sileni, Paolo Fava, et al.. (2021). Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy). Targeted Oncology. 16(6). 789–799. 5 indexed citations

10.

Zaniboni, Alberto, Carlo Barone, Maria Banzi, et al.. (2021). Italian Results of the PRECONNECT Study: Safety and Efficacy of Trifluridine/tipiracil in Metastatic Colorectal Cancer. Future Oncology. 17(18). 2315–2324. 6 indexed citations

11.

Mallio, Carlo Augusto, Andrea Napolitano, Francesco Giordano, et al.. (2021). Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis. Cancers. 13(4). 652–652. 22 indexed citations

12.

Spoto, Silvia, Emanuele Valeriani, E. Riva, et al.. (2020). A Staphylococcus aureus Coinfection on a COVID-19 Pneumonia in a Breast Cancer Patient. SHILAP Revista de lepidopterología. 2 indexed citations

13.

Vincenzi, Bruno, Ajay Duggal, Pamela Guglielmini, et al.. (2020). Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial. BMJ Open. 10(2). e030114–e030114. 11 indexed citations

14.

Lolli, Cristian, Delia De Lisi, Vincenza Conteduca, et al.. (2019). Testosterone levels and androgen receptor copy number variations in castration‐resistant prostate cancer treated with abiraterone or enzalutamide. The Prostate. 79(11). 1211–1220. 16 indexed citations

15.

Fioramonti, Marco, Valentina Fausti, Francesco Pantano, et al.. (2018). Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment. Scientific Reports. 8(1). 4177–4177. 38 indexed citations

16.

Bertani, Francesca Romana, Pamela Mozetic, Marco Fioramonti, et al.. (2017). Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis. Scientific Reports. 7(1). 8965–8965. 178 indexed citations

17.

Piredda, Michela, Gabriella Facchinetti, Valentina Biagioli, et al.. (2017). Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy: A pilot randomised controlled trial. European Journal of Cancer Care. 26(6). e12757–e12757. 48 indexed citations

18.

Cappa, Marco, et al.. (2015). GH therapy in transition age: state of the art and future perspectives.. PubMed. 40(1). 23–35. 3 indexed citations

19.

Vincenzi, Bruno, et al.. (2015). Emerging kinase inhibitors of the treatment of gastric cancer. Expert Opinion on Emerging Drugs. 20(3). 479–493. 12 indexed citations

20.

Tornese, Gianluca, Laura Rubert, Giuseppe Tonini, & Elena Faleschini. (2011). Uno, cento, mille diabeti Diabete mellito di tipo 1 e 2 - parte prima. Medico e Bambino. 30(6). 360–366.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact